Concepedia
Statistics
Publications
12
Citations
409
H-Index
11
Active since
2006
Affiliations
Monash University(Current)
Servier (France)
Novartis Institutes for BioMedical Research
Novartis (Switzerland)
Plateforme Technologique d'Innovation Biomédicale
Darren Riddy is an author at Monash University specializing in medicine, pharmacology, and pharmacotherapy.
Top concepts
MedicinePharmacologyAllergyPathologyImmunologyDrug DiscoveryPharmacotherapyLiverAsthmaHealth
Publications per year
2006–2022
Investigating the molecular mechanisms through which <scp>FTY</scp>720‐<scp>P</scp> causes persistent <scp>S1P<sub>1</sub></scp> receptor internalization
David A. Sykes, Darren Riddy, Craig Stamp et al. · British Journal of Pharmacology · 2014 · 73 citations · Full text
Fevipiprant (QAW039), a Slowly Dissociating CRTh2 Antagonist with the Potential for Improved Clinical Efficacy
David A. Sykes, Michelle Bradley, Darren Riddy et al. · Molecular Pharmacology · 2016 · 67 citations · Full text
Acetylcholine Muscarinic M4 Receptors as a Therapeutic Target for Alcohol Use Disorder: Converging Evidence From Humans and Rodents
Leigh C. Walker, Alice E. Berizzi, Nicola A. Chen et al. · Biological Psychiatry · 2020 · 47 citations · Full text
Substance Abuse, Substance Use, Psychiatry +11
Comparative genotypic and phenotypic analysis of human peripheral blood monocytes and surrogate monocyte-like cell lines commonly used in metabolic disease research
Darren Riddy, Emily Goy, Philippe Delerive et al. · PLoS ONE · 2018 · 42 citations · Full text
Immunology, Blood Cell, Pathology +23
Discovery of Fevipiprant (NVP-QAW039), a Potent and Selective DP<sub>2</sub> Receptor Antagonist for Treatment of Asthma
David A. Sandham, Lucy Barker, Lyndon Brown et al. · ACS Medicinal Chemistry Letters · 2017 · 31 citations · Full text
1–5 of 12